• Income Statement
• Balance Sheet
• Cash Flow
• Ratios
• Market Data
• Valuation

	Drugs Made In America Acquisition Corp. (DMAA)
	Q2-CY2026	Q1-CY2026	Q4-CY2025	Q3-CY2025	Q2-CY2025	Q1-CY2025	Q4-CY2024	Q3-CY2024	Q2-CY2024	Q1-CY2024	Q4-CY2023	Q3-CY2023	Q2-CY2023	Q1-CY2023	Q4-CY2022	Q3-CY2022	Q2-CY2022	Q1-CY2022	Q4-CY2021	Q3-CY2021	Q2-CY2021	Q1-CY2021	Q4-CY2020	Q3-CY2020	Q2-CY2020	Q1-CY2020	Q4-CY2019	Q3-CY2019	Q2-CY2019	Q1-CY2019	Q4-CY2018	Q3-CY2018	Q2-CY2018	Q1-CY2018	Q4-CY2017	Q3-CY2017	Q2-CY2017	Q1-CY2017	Q4-CY2016	Q3-CY2016	Q2-CY2016	Q1-CY2016	Q4-CY2015	Q3-CY2015	Q2-CY2015	Q1-CY2015	Q4-CY2014	Q3-CY2014	Q2-CY2014
Balance Sheet Date			2025-Dec-31	2025-Sep-30	2025-Jun-30	2025-Mar-31	2024-Dec-31
Fiscal Period			Q4-FY2025	Q3-FY2025	Q2-FY2025	Q1-FY2025	Q4-FY2024
Close Price of Common Stock	10.51$	10.50$	10.31$	10.27$	10.18$	10.01$
Market Cap of Common Stock	352,265,173$	351,930,002$	345,394,159$	344,221,059$	341,204,516$
QoQ%	.10%	1.89%	.34%	.88%
YoY%	3.24%
Common Shares Outstanding	33,717,143		10,717,143	10,517,143	10,517,143	10,517,143	9,857,143	9,857,143	9,857,143
QoQ%			1.90%	.00%	.00%	6.70%	.00%	.00%
YoY%	220.59%		8.73%	6.70%	6.70%
Price to Sales
Price to Earnings	59.30x	59.24x	58.14x
Price to Book	-	-	-	-	-
Total Revenue
QoQ%
YoY%
TTM
TTM_QoQ%
TTM_YoY%
Gross Margin
QoQ
YoY
Operating Income			(2,089,466$)	(263,703$)	(131,919$)	(330,925$)		(144,928$)
QoQ%			(692.36%)	(99.90%)	60.14%
YoY%				(81.95%)
TTM			(2,816,013$)
TTM_QoQ%
TTM_YoY%
Operating Margin
QoQ
YoY
Net Income			212,958$	2,184,563$	2,288,579$	1,254,543$		(144,928$)
QoQ%			(90.25%)	(4.55%)	82.42%
YoY%				1,607.34%
TTM			5,940,643$
TTM_QoQ%
TTM_YoY%
Profit Margin
QoQ
YoY
Equity to Common Shareholders			(7,263,981$)	(7,328,415$)	(7,151,715$)	(7,176,350$)	(244,845$)	(164,859$)	(19,931$)
QoQ			64,434$	(176,700$)	24,635$	(6,931,505$)	(79,986$)	(144,928$)
QoQ%			.88%	(2.47%)	.34%	(2,830.98%)	(48.52%)	(727.15%)
YoY			(7,019,136$)	(7,163,556$)	(7,131,784$)
YoY%			(2,866.77%)	(4,345.26%)	(35,782.37%)
Dividends Paid
Additional Paid-In Capital QoQ
Treasury Stock
QoQ
Goodwill
QoQ%
YoY%
Other Intangible Assets
QoQ
Amortization of Intangible Assets
Total Assets			239,918,847$	237,632,428$	235,205,692$	232,806,487$	550,824$
QoQ			2,286,419$	2,426,736$	2,399,205$	232,255,663$
YoY			239,368,023$
Total Liabilities			7,276,172$	7,356,611$	7,201,441$	7,247,369$	795,669$
QoQ			(80,439$)	155,170$	(45,928$)	6,451,700$
YoY			6,480,503$
Current Ratio			.03x	.06x	.16x	.20x	.01x
Total Current Assets			12,191$	28,196$	49,726$	71,019$	4,991$
QoQ			(16,005$)	(21,530$)	(21,293$)	66,028$
Total Current Liabilities			376,172$	456,611$	301,441$	347,369$	795,669$
QoQ			(80,439$)	155,170$	(45,928$)	(448,300$)
Debt to Asset Ratio			.03x	.03x	.03x	.03x	1.44x
Long Term Debt
QoQ
YoY
Capital Lease Obligations
Cash and Cash Equivalents
QoQ
YoY
Interest Expenses
Interest Income			2,302,424$	2,448,266$	2,420,498$	1,585,468$

Copy Table ✓